Revolution Medicines valuation
$162.69Change from previous close: −2.50%Absolute change: −$4.18
Valuation
The average price target of 24 analysts is $274.76.
Data as of November 15, 2026
Revolution Medicines compared with similar companies
Revolution Medicines's Price/book: 15.5, +92% against the median of a group of 11 similar companies (8.06).
| Metric | Revolution Medicines | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| Price/book | 15.5 | 8.06 | 5.30 – 13.1 | High |
| Price/sales | 188.6 | 9.44 | 6.70 – 15.0 | High |
| Gross margin | 0.0% | 77.3% | 57.9% – 90.7% | Low |
| Operating margin | -853.0% | 19.5% | -48.6% – 32.1% | Low |
| Net margin | 0.0% | 13.9% | 0.0% – 33.6% | Middle |
| ROE | -93.6% | 10.0% | -8.4% – 37.8% | Low |
| Debt/equity | 0.50 | 0.30 | 0.02 – 0.67 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Other metrics
Valuation multiples
- Market cap
- $37.27B
- Enterprise value
- $34.83B
- P/E (trailing 12 months)
- -20.9
- Forward P/E
- -55.6
- EV/EBITDA
- -20.8
- EV/revenue
- 176.3
Profitability and growth
- ROA
- -32.1%
- ROIC
- -30.7%
Financial health
- Total cash
- $3.65B
- Total debt
- $1.21B
- Current ratio
- 8.36
- Quick ratio
- 8.16
- Altman Z-Score
- 6.63
- Piotroski F-Score
- 2.00
Dividends
- Dividend yield
- 0.0%
Analysts and estimates
- Average price target
- $274.76
- Median price target
- $272.00
- High price target
- $350.00
- Low price target
- $179.00
- Analysts with a price target
- 24
- Consensus
- Strong buy
- Forward EPS
- -$3.10
- EPS estimate, current year
- -$8.30
Shares and trading
- Beta
- 1.43
- Average volume
- 2.18M
- Shares outstanding
- 216.29M
- Float
- 186.56M
- Institutional ownership
- 103.9%
- Insider ownership
- 3.9%
- Short interest (% of float)
- 6.4%
- Short ratio (days)
- 6.78
